Business Context and Reporting Period
This Form 8-K Current Report was filed by Anavex Life Sciences Corp. on March 4, 2008, covering events occurring on January 21, 2008, and effective February 29, 2008. The company is incorporated in Nevada with principal executive offices in Geneva, Switzerland.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the current period. However, it notes that the independent accountant's reports for the fiscal years ended December 31, 2006, and 2005, included an explanatory paragraph regarding uncertainty as to the company's ability to continue as a going concern.
Material Changes
- Change in Certifying Accountant: Amisano Hanson, Chartered Accountant, resigned as the independent accountant on January 21, 2008. The resignation coincides with Amisano Hanson merging its operations into BDO Dunwoody LLP.
- Engagement of New Accountant: Concurrent with the resignation, the company engaged BDO Dunwoody as its new independent accountant, approved by the board of directors.
- Executive Departure: Angela Vernadaki resigned as Vice President of Business Development, effective February 29, 2008.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the historical going concern uncertainty noted in prior audit reports. There were no disagreements with the former accountant regarding accounting principles, practices, or audit scope during the relevant periods.
Investor Verification Checklist
- Verify the status of the company's "going concern" uncertainty as highlighted in the 2005 and 2006 audit reports.
- Confirm the transition timeline and audit scope between Amisano Hanson and BDO Dunwoody.
- Assess the impact of the Vice President of Business Development's departure on ongoing operations.
- Review the letter from Amisano Hanson (Exhibit 16.1) for any additional context on the resignation.